115 related items for PubMed ID: 3237907
1. Neuroendocrine aspects of primary endogenous depression: VI. Receiver operating characteristic analysis of the cortisol suppression index versus the dexamethasone suppression test in patients and matched controls.
McCracken JT, Rubin RT, Poland RE.
Psychiatry Res; 1988 Oct; 26(1):69-78. PubMed ID: 3237907
[Abstract] [Full Text] [Related]
2. Neuroendocrine aspects of primary endogenous depression: IX. Receiver operating characteristic analysis of the dexamethasone suppression index vs. the dexamethasone suppression test in patients and controls.
McCracken JT, Rubin RT, Poland RE.
Psychiatry Res; 1990 Jan; 31(1):49-56. PubMed ID: 2315422
[Abstract] [Full Text] [Related]
3. Neuroendocrine aspects of primary endogenous depression: XII. Receiver operating characteristic and kappa analyses of serum and urine cortisol measures in patients and matched controls.
Thompson LM, Rubin RT, McCracken JT.
Psychoneuroendocrinology; 1992 Oct; 17(5):507-15. PubMed ID: 1484917
[Abstract] [Full Text] [Related]
4. Do serum dexamethasone levels improve the DST?
Mossman D, Somoza E.
J Affect Disord; 1990 Sep; 20(1):13-8. PubMed ID: 2147186
[Abstract] [Full Text] [Related]
5. A comparison of the cortisol suppression index and the dexamethasone suppression test.
Laux G, Schlesser MA, Rush AJ, Orsulak P, Weissenburger J.
J Clin Psychiatry; 1984 Oct; 45(10):431-2. PubMed ID: 6480568
[Abstract] [Full Text] [Related]
6. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
Deuschle M, Schweiger U, Gotthardt U, Weber B, Körner A, Schmider J, Standhardt H, Lammers CH, Krumm B, Heuser I.
Biol Psychiatry; 1998 May 15; 43(10):762-6. PubMed ID: 9606531
[Abstract] [Full Text] [Related]
7. Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls.
Rubin RT, Poland RE, Lesser IM, Winston RA, Blodgett AL.
Arch Gen Psychiatry; 1987 Apr 15; 44(4):328-36. PubMed ID: 3566455
[Abstract] [Full Text] [Related]
8. The dex/CRH test--is it better than the DST?
Watson S, Gallagher P, Smith MS, Ferrier IN, Young AH.
Psychoneuroendocrinology; 2006 Aug 15; 31(7):889-94. PubMed ID: 16701957
[Abstract] [Full Text] [Related]
9. Plasma dexamethasone concentrations and the dexamethasone suppression test.
Ritchie JC, Belkin BM, Krishnan KR, Nemeroff CB, Carroll BJ.
Biol Psychiatry; 1990 Jan 15; 27(2):159-73. PubMed ID: 2294980
[Abstract] [Full Text] [Related]
10. The lower limits of dexamethasone window in Chinese depressives.
Shiah IS, Ko HC, Lu RB.
Biol Psychiatry; 1998 Oct 01; 44(7):648-55. PubMed ID: 9787892
[Abstract] [Full Text] [Related]
11. Plasma cortisol and 11-deoxycortisol activity in depressed patients and normal volunteers.
Schweitzer I, Tuckwell VM, Maguire KP, Tiller JW, Harrison LC, Davies BM.
Psychoneuroendocrinology; 1991 Oct 01; 16(5):375-82. PubMed ID: 1805291
[Abstract] [Full Text] [Related]
12. A modified dexamethasone suppression test for endogenous depression.
Poland RE, Rubin RT, Lane LA, Martin DJ, Rose DE, Lesser IM.
Psychiatry Res; 1985 Aug 01; 15(4):293-9. PubMed ID: 3865246
[Abstract] [Full Text] [Related]
13. Neuroendocrine aspects of primary endogenous depression. III. Cortisol secretion in relation to diagnosis and symptom patterns.
Rubin RT, Poland RE, Lesser IM, Martin DJ, Blodgett AL, Winston RA.
Psychol Med; 1987 Aug 01; 17(3):609-19. PubMed ID: 3628622
[Abstract] [Full Text] [Related]
14. Effect of high plasma dexamethasone levels on DST sensitivity: dose-response study in depressed patients and controls.
Hunt GE, O'Sullivan BT, Johnson GF, Caterson ID.
Psychiatry Res; 1991 Feb 01; 36(2):209-22. PubMed ID: 2017535
[Abstract] [Full Text] [Related]
15. The influences of dexamethasone levels on the predictive value of the DST for unipolar major depression and the relationships between post-dexamethasone cortisol and ACTH levels.
Maes M, Minner B, Suy E.
J Affect Disord; 1989 Feb 01; 17(1):39-46. PubMed ID: 2544636
[Abstract] [Full Text] [Related]
16. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
Poland RE, Rubin RT, Lesser IM, Lane LA, Hart PJ.
Arch Gen Psychiatry; 1987 Sep 01; 44(9):790-5. PubMed ID: 3632252
[Abstract] [Full Text] [Related]
17. The cortisol suppression index and the dexamethasone suppression test in major depression.
Maes M, De Ruyter M, Suy E.
Acta Psychiatr Belg; 1987 Sep 01; 87():633-9. PubMed ID: 3452982
[Abstract] [Full Text] [Related]
18. Dynamics of the cortisol suppression index in depression.
Bernstein JP, Chung SY.
J Clin Psychiatry; 1984 Oct 01; 45(10):433-6. PubMed ID: 6480569
[Abstract] [Full Text] [Related]
19. The dexamethasone suppression index: enhancement of DST diagnostic utility for depression by expressing serum cortisol as a function of serum dexamethasone.
Arana GW, Reichlin S, Workman R, Haaser R, Shader RI.
Am J Psychiatry; 1988 Jun 01; 145(6):707-11. PubMed ID: 3369557
[Abstract] [Full Text] [Related]
20. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects.
Carson SW, Halbreich U, Yeh CM, Asnis G, Goldstein S.
Biol Psychiatry; 1988 Sep 01; 24(5):569-77. PubMed ID: 3167145
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
